To evaluate the resolution of contact lens-induced corneal warpage before keratorefractive surgery.
We prospectively studied the eyes of 165 consecutive contact lens-wearing patients evaluated for keratorefractive surgery. Significant contact lens-induced corneal warpage was detected by corneal topography in 20 eyes of 11 patients. Manifested refraction, keratometry, and cornea topography were subsequently recorded during weekly or biweekly reevaluations and were compared with previous measurements for stability. Effects of age, sex, type, and duration of contact-lens wear and the recovery time period to stabilization were analyzed.
Overall, a 12% incidence of significant contact lens-induced corneal warpage was found. In patients demonstrating lens-associated warpage, the mean duration of prior contact lens wear was 21.2 years (range 10 to 30 years); lens use included daily wear soft (n=2), extended-wear soft (n=6), toric (n=4), and rigid gas-permeable contact lenses (n=8). Up to 3.0 diopter (D) refractive and 2.5D keratometric shifts accompanied by significant topography pattern differences were observed. The average recovery time for stabilization of refraction, keratometry (change within ± 0.5D), and topography pattern was 7.8 ± 6.7 weeks (range 1 to 20 weeks). Recovery rates differed between the lens types: soft extended-wear 11.6 ± 8.5 weeks, soft toric lens 5.5 ± 4.9 weeks, soft daily wear 2.5 ± 2.1 weeks, and rigid gas-permeable 8.8 ± 6.8 weeks.
We observed a 12% incidence of significant contact lens-induced corneal warpage in patients undergoing evaluation for keratorefractive surgery. Warpage occurred with all types of contact lens wear but resolved at different rates. To optimize the quality and predictability of keratorefractive procedures, an appropriate waiting period is necessary for contact lens-induced corneal warpage to stabilize. We suggest that resolution of corneal warpage be documented by stable serial manifested refractions, keratometry, and corneal topographic patterns before scheduling patients for keratorefractive surgery.
From the Department of Ophthalmology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
Accepted March 22, 2002.
1Supported in part by an unrestricted research grant from Research to Prevent Blindness, Inc., New York, New York.
Address correspondence to: H. Dwight Cavanagh, M.D., Ph.D., Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9057. Phone 214-648-8074; fax 214-648-9061; e-mail: dwight.cavanagh@UTSouthwestern.edu.
The authors have no financial interest in the products discussed in this study.